Market Access - Research and Advisory Services

Continued commercial success of pharmaceutical products and biologics depends largely on the ability of bio-pharmaceutical companies to evolve their Market Access structures, processes and outcomes to work effectively in the current payer-driven environment. In fact, it is estimated that third-party payers in the Market Access sector currently control more than 80 percent of patient access to prescription drugs in the United States.

The payer, market access and reimbursement landscape will continue to change over the next few years being at the heart of current health care debates and policies.

Benchmarking and assessment tools provided by Best Practices, LLC's Research and Advisory Services have aided many leading pharmaceutical and biotech companies perfect their Market Access strategies by answering critical questions around:

• Optimal structure and organizational fit of Market Access Groups
• Key Global Market Access Activities
• Staffing and Resource Allocation Levels
• Access Strategies for Employers, Hospitals, Medicaid, Medicare, Long-term Care and Other Payer Groups
• Pricing and Contracting Strategies
• Trends in Use of Vendors to Gather Payer Information
• Account Management and Pull-through Marketing Tactics
• Access and Reimbursement Strategies

Explore these and other topics with us during a Virtual Presentation of our resources, capabilities and solutions tailored to support your success.

Benefits of a Partnership with Research and Advisory Services

• Decision Support Research to Benchmark Your Function and Learn from Best-in-Class Market Access Groups
• Access to Strategic Research Projects around Market Access Excellence
• Unlimited Access to the Best Practice Database for Quick Access to Key Best Practices and Metrics
• Personal Interaction with Senior Analysts With Years of Experience in Benchmarking Market Access
• Exclusive Networking Forums for Market Access Professionals